12-07-2018 08:07 AM CET - Health & Medicine
Print

Hemostats Market Analysis with Global Key Players CryoLife, Inc., Biom'up, Arch Therapeutics Inc, Anika Therapeutics, RESORBA Medical GmbH, 3-D Matrix, Inc., B. Braun Group, Vascular Solutions, Baxter International Inc., CR Bard, Pfizer, Ethicon, Inc., Me

Press release from: Data Bridge Market Research

"Hemostats"


Hemostats Market Report deliver comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the Hemostats Market. The objective of Hemostats Market report is to provide a detailed analysis of Hemostats industry and its impact based on applications and on different geographical regions, strategically analyses the growth trends, future prospects. Analysis and discussion of important industry trends, market size, market share estimates are mentioned in the report. Hemostats Market report also delivers lists of the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the Hemostats Industry.

Global Hemostats Market Research Report: By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Forecast to 2024

Global Hemostats Market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Sample Copy of this Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Key Company Profiles:

• Ethicon US LLC (U.S.),
• Pfizer,
• C.R. Bard Inc.,
• Baxter,
• Vascular Solutions, Inc.,
• B.Braun Melsungen,
• 3-D Matrix, Ltd.,
• Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company),
• Anika Therapeutics, Inc.,
• Arch Therapeutics Inc.,
• Biom’Up SAS,
• CryoLife, Inc.,
• Gamma Therapeutics, Inc.,
• Hemostasis, LLC,
• MedTrade Products Limited,
• Integra LifeSciences Corporation,
• Medline Industries, Inc.,
• HEMOTEC MEDICAL GMBH,
• Stryker,
• CSL Behring,
• Mallinckrodt,
• Equimedical, B.V.

Key Drivers of Global Hemostats Market:

Some of the major factors driving the market for hemostats market are increasing number of surgeries, technological advancement, increasing healthcare expenditure and infrastructure. These factors are increasing the demand for different heomostatic agents.

• Reluctance of surgeons towards new products may hinder the growth of this market.

• The weak reimbursement scenario will hamper the growth of the market for new and innovative therapies or hemostats products, causing companies to withdraw from the market thus increasing the hospital costs putting all burdens onto the patient for treatment.

This report consists of below pages:

• No of pages: 278
• No of Figures: 241
• No of Tables: 237

Order a Copy of Global Hemostats Market Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Segmentation : Global Hemostats Market

The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

On the basis of application:

• Surgery
• Wound Closure

On the basis of end users:

• Hospitals
• Community Healthcare
• Ambulatory Centres
• Clinics

On the basis of geography:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Frequently Asked Questions:

- What will the market size be in 2024?
- What are the key factors driving the global market?
- What are the challenges to market growth?
- Who are the key players in the market?
- What are the market opportunities and threats faced by the key players?
- What will be the growth rate in 2024?
- Which strategies are used by top players in the Global Hemostats Market?

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Table of Contents:

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW

4. PREMIUM INSIGHTS

5. REGULATORY

6. REIMBURSEMENT

7. EXECUTIVE SUMMARY

8. GLOBAL HEMOSTATS MARKET, BY TYPE

9. GLOBAL HEMOSTATS MARKET,BY APPLICATION

10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL

11. GLOBAL HEMOSTATS MARKET, BY END USER

12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY

13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE

14. COMPANY PROFILES

14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)

14.1.1. COMPANY OVERVIEW
14.1.2. REVENUE ANALYSIS
14.1.3. PRODUCT PORTFOLIO
14.1.4. RECENT DEVELOPMENTS

14.2. PFIZER

14.2.1. COMPANY OVERVIEW
14.2.2. REVENUE ANALYSIS
14.2.3. PRODUCT PORTFOLIO
14.2.4. RECENT DEVELOPMENTS

14.3. C.R BARD

14.3.1. COMPANY OVERVIEW
14.3.2. REVENUE ANALYSIS
14.3.3. PRODUCT PORTFOLIO
14.3.4. RECENT DEVELOPMENTS

14.4. BAXTER

14.4.1. COMPANY OVERVIEW
14.4.2. REVENUE ANALYSIS
14.4.3. PRODUCT PORTFOLIO
14.4.4. RECENT DEVELOPMENTS

14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)

14.5.1. COMPANY OVERVIEW
14.5.2. REVENUE ANALYSIS
14.5.3. PRODUCT PORTFOLIO
14.5.4. RECENT DEVELOPMENTS

14.6. B.BRAUN MELSUNGEN AG

14.6.1. COMPANY OVERVIEW
14.6.2. REVENUE ANALYSIS
14.6.3. PRODUCT PORTFOLIO
14.6.4. RECENT DEVELOPMENTS

14.7. 3-D MATRIX LTD

14.7.1. COMPANY OVERVIEW
14.7.2. REVENUE ANALYSIS
14.7.3. PRODUCT PORTFOLIO
14.7.4. RECENT DEVELOPMENTS

14.8. RESORBA MEDICAL GMBH

14.8.1. COMPANY OVERVIEW
14.8.2. REVENUE ANALYSIS
14.8.3. PRODUCT PORTFOLIO
14.8.4. RECENT DEVELOPMENTS

14.9. ANIKA THERAPEUTICS, INC.

14.9.1. COMPANY OVERVIEW
14.9.2. REVENUE ANALYSIS
14.9.3. PRODUCT PORTFOLIO
14.9.4. RECENT DEVELOPMENTS

14.10. BIOM’UP

14.10.1. COMPANY OVERVIEW
14.10.2. REVENUE ANALYSIS
14.10.3. PRODUCT PORTFOLIO
14.10.4. RECENT DEVELOPMENTS

14.11. CRYOLIFE, INC.

14.11.1. COMPANY OVERVIEW
14.11.2. REVENUE ANALYSIS
14.11.3. PRODUCT PORTFOLIO
14.11.4. RECENT DEVELOPMENTS

14.12. EQUIMEDICAL

14.12.1. COMPANY OVERVIEW
14.12.2. REVENUE ANALYSIS
14.12.3. PRODUCT PORTFOLIO
14.12.4. RECENT DEVELOPMENTS

14.13. HEMOSTASIS, LLC

14.13.1. COMPANY OVERVIEW
14.13.2. REVENUE ANALYSIS
14.13.3. PRODUCT PORTFOLIO
14.13.4. RECENT DEVELOPMENTS

14.14. MEDTRADE PRODUCTS LIMITED

14.14.1. COMPANY OVERVIEW
14.14.2. REVENUE ANALYSIS
14.14.3. PRODUCT PORTFOLIO
14.14.4. RECENT DEVELOPMENTS

14.15. STRYKER

14.15.1. COMPANY OVERVIEW
14.15.2. REVENUE ANALYSIS
14.15.3. PRODUCT PORTFOLIO
14.15.4. RECENT DEVELOPMENTS

14.16. ARCH THERAPEUTICS, INC.

14.16.1. COMPANY OVERVIEW
14.16.2. REVENUE ANALYSIS
14.16.3. PRODUCT PORTFOLIO
14.16.4. RECENT DEVELOPMENTS

14.17. INTEGRA LIFESCIENCES CORPORATION

14.17.1. COMPANY OVERVIEW
14.17.2. REVENUE ANALYSIS
14.17.3. PRODUCT PORTFOLIO
14.17.4. RECENT DEVELOPMENTS

14.18. ALTAYLAR MEDICAL

14.18.1. COMPANY OVERVIEW
14.18.2. REVENUE ANALYSIS
14.18.3. PRODUCT PORTFOLIO
14.18.4. RECENT DEVELOPMENTS

14.19. BIOCER ENTWICKLUNGS-GMBH

14.19.1. COMPANY OVERVIEW
14.19.2. REVENUE ANALYSIS
14.19.3. PRODUCT PORTFOLIO
14.19.4. RECENT DEVELOPMENTS

14.20. SMI (STARCH MEDICAL)

14.20.1. COMPANY OVERVIEW
14.20.2. REVENUE ANALYSIS
14.20.3. PRODUCT PORTFOLIO
14.20.4. RECENT DEVELOPMENTS

15. RELATED REPORTS

View Full Report @ databridgemarketresearch.com/reports/global-hemostats-mar...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1424097 • Views: 180
More releasesMore releases

You can edit or delete your press release here: